Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What was added/deleted to the latest presentation release on October 17th? Anyone comb through and find something comparatively?
Long and strong on INNV since .09!
Yes, that's why I think we need a partnership with BP. This would provide credence to the stock and drug. In turn institutional funds would move in and buy into what the company is "selling." This in turn would provide stability to the stock.
See how the horse must move before the cart?
Of course, with good news we should fly. The question however, is why can't the stock maintain its gains? It seems pop and drop is the MO.
Market makers stacking the ASK at .275, preventing an upward trajectory. We need volume to stop this type of crud.
Yes, I agree. However, the point I was making is that the ASKS are not stooping down to the Bids. If you want the stock, the bids will need to be increased (as long as the asks remain where they are).
AT least the level 2 ASKS are increased. There's one small ask at .275, 3 at .30, and the next one is .39.
So that's a good sign, now we need the BIDS to start slapping the ask and we'll be in the high 30's in a very short time.
Source: http://www.otcmarkets.com/stock/INNV/quote
It's going to be a good day for INNV today. Nice interview by Hoffman. They're serious about up listing and appreciating the share price.
Expecting partnership before filing.
The market is closed Monday due to the labor day holiday.
Look at level 2 quotes. Need to knock out a few asks at .32, and then we jump to .36. Am I reading that right, at least per a level 2 standpoint?
http://www.otcmarkets.com/stock/INNV/quote
Yes, some differences. I like the part about publishing peer reviewed journals. Hope it's sooner rather than later.
My point (as a LONG) is that there is virtually nothing new in that PR. It's a fluff piece.
CJ, that is a regurgitation of a previous PR. And now you can't access that article on Yahoo. What's going on??
I agree, a 10/1 is highly unlikely, I just used it for easy math purposes.
More likely than not they will not R/S, (perhaps 2/1 R/S) because they need volume to be liquid. It's at a good stage right now with 96 million shares.
A R/S is not all that bad. The value of your holding remains the same.
Ex: 10:1 R/S:
10,000 shares @ 0.30 = $3,000
1,0000 shares @ 3.00 = $3,000
Look at AVXL. They did a R/S early 2016 (I believe)and went from around $4 to $14 before the air out of the balloon leaked. More to do with their science though. Innovus has products generating millions in revs. Diff story!
A R/S will get us access to institutions and much less share dickering around like we're experiencing now.
We need some volume. Possibly the "calm before the storm."
Company has been quiet on fluticare presses, supposedly suggesting as we get closer to the approval date, there is no reason to pump.
Goose, did you load up? Volume says otherwise.
What did Adam say? Sorry I don't have twitter.
Someone got impatient and sold some 150K or so.
Under what name has fluticare been dispensed via prescription in the USA? The doctor and pharmacist i spoke with in the U.S. had never heard of fluticare.
Jd, perhaps, but why is it taking unusually long. That's disconcerting for me.
50% of novalere's shares are in escrow for 18 months since the date of the merger. If the anda is approved they get the remaining 50% shares but it must happen within 18 months. This make is October 2016. Am I reading that right?
Now my bigger protest against this co, per my understanding Fluticare rx is not prescribed in the US. They have sold millions of units outside the US.
I asked a doctor and a pharmacist, neither have heard of "fluticare." They are both aware of fluticasone. I don't believe fluticare rx is available in the states. Someone please confirm or verify otherwise.
Why does the company make it seem like fluticare is approved for prescription in the USA, when that is not the case? Fluticasone is prescribed in the US but not fluticare.
Mongoose, based on what do you believe the run to .70 is close?
Buying pressure is really picking up. Sorry RFB. Looks like we may be setting up for the next leg up after a nice base in the .39/.40 range. I won't be surprised if we're in the .60's next week. You know how quickly this stock moves!
The future of Innovus is undoubtedly bright. 5 mil in projected revs w/o fluticare this year alone. Just imagine what it can be with fluticare. Regardless, this is a legitimate company as it stands with 5 mil in revs and growing! Up listing and approval are next along with 3 new product launches.
I don't see how anyone would dump with the potential approval of fluticare any day. There's no way you're gonna catch me on the sidelines. Holding since .09.
RFB, yea for 2500 shares? Who cares!
Sorry you won't be buying in as low as you would like. Get in now (early 40's before the rocket ship takes off)!
Shawn,
Ofcourse the approval of fluticare is not a 100% guarantee. If it was then it would already be reflected in the current share price (baked in). However because it's not baked into the share price, this is why we have tremendous upside, with of course a degree of risk (rejection of fluticare).
Although I would concede that the FDA is not beyond reproach. I would not count on a FDA conspiracy to reject fluticare.
Folks throwing around random arbitrary percentages of approval and rejection are simply that...Random & arbitrary.
Locked in since .09 for a good sum of shares. You can't argue management is hell-bent on the success of the company. Including fluticare approval, up listing to a major exchange, Beyond Human products, and potentially a buy-out.
I don't spot any diluting activities on level 2 quotes whatsoever. MM's are buying and selling to one another. I would argue the buying pressure is much greater based on what I see.
Check it out yourselves: http://www.otcmarkets.com/stock/INNV/quote
Who is trying to manipulate the share price via a .41 ask? Raise the ASK!
Bashers are hard at work today. Namely RBR. Probably the same guy who goes by the username Jacob, stockzoom, etc.
Fluticare is days to weeks away. I don't dare sell because you never know when approval will hit the wire. No one knows for that matter, aside from FDA reviewers.
I will sell at $1.50 upon approval and/or uplisting.
I've called and left messages probably 5 times in the last 7 months and not one has been returned.
Suds, how were you able to get a hold of Averback?
Yes, but the search also tags "17 hours ago" with it.
Can someone that's a computer/internet whiz explain why when you google "Fluticare" and set within 24 hours that we get the FDA site as option 2:
Although it's not published yet can it be "lurking" in the background?
During the CC yesterday, Damaj stated he was confident Fluticare would be approved. He went on to state that the company spent $5 million in acquiring fluticare OTC rights and they did this based on a great deal of confidence.
You'll never know when that PR will come through on approval. I'm sitting pat and waiting out any temporary volatility. You don't want to be on the sidelines when the PR comes through.
400K bid @ .50. Someone plz fill me up!
Q2 earnings PR is now OFFICIALLY OUT!
It's too bad, because the company has a lot going for it. Damaj is hell bent on up listing and getting this into the hands of the big boys.